Péter Hauser

7.1k total citations · 1 hit paper
111 papers, 5.2k citations indexed

About

Péter Hauser is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, Péter Hauser has authored 111 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Hepatology, 30 papers in Epidemiology and 22 papers in Molecular Biology. Recurrent topics in Péter Hauser's work include Hepatitis C virus research (36 papers), Liver Disease Diagnosis and Treatment (25 papers) and Bipolar Disorder and Treatment (15 papers). Péter Hauser is often cited by papers focused on Hepatitis C virus research (36 papers), Liver Disease Diagnosis and Treatment (25 papers) and Bipolar Disorder and Treatment (15 papers). Péter Hauser collaborates with scholars based in United States, Austria and Japan. Péter Hauser's co-authors include Jennifer M. Loftis, Mitchel A. Kling, Christina A. Meyers, Alan Valentine, Marilyn Huckans, B D Weintraub, Benjamin J. Morasco, A. James Mixson, John A. Matochik and Elliott Richelson and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Péter Hauser

111 papers receiving 5.0k citations

Hit Papers

Effectiveness of Adjunctive Antidepressant Treatment for ... 2007 2026 2013 2019 2007 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Péter Hauser United States 37 1.4k 935 902 878 684 111 5.2k
Dimitrios Vassilopoulos Greece 42 523 0.4× 1.2k 1.3× 1.7k 1.9× 1.0k 1.2× 96 0.1× 273 6.2k
Tatsuyuki Kakuma Japan 45 1.3k 0.9× 242 0.3× 574 0.6× 1.5k 1.7× 103 0.2× 233 6.8k
Lori B. Chibnik United States 47 649 0.5× 119 0.1× 310 0.3× 1.6k 1.8× 245 0.4× 159 6.3k
Dong Zhou China 44 531 0.4× 76 0.1× 211 0.2× 2.2k 2.5× 771 1.1× 107 5.5k
Natália Pessoa Rocha Brazil 35 869 0.6× 46 0.0× 422 0.5× 682 0.8× 693 1.0× 138 3.9k
Carlo Vergani Italy 37 314 0.2× 90 0.1× 334 0.4× 808 0.9× 214 0.3× 143 3.8k
Péter Sótonyi Hungary 30 260 0.2× 55 0.1× 482 0.5× 821 0.9× 160 0.2× 269 4.3k
Martha M. Faraday United States 25 981 0.7× 26 0.0× 713 0.8× 1.6k 1.8× 95 0.1× 37 5.4k
Karl‐Heinz Schulz Germany 32 430 0.3× 455 0.5× 356 0.4× 181 0.2× 125 0.2× 138 3.3k
John J. Kelly United States 52 153 0.1× 86 0.1× 685 0.8× 1.3k 1.5× 39 0.1× 225 8.5k

Countries citing papers authored by Péter Hauser

Since Specialization
Citations

This map shows the geographic impact of Péter Hauser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Péter Hauser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Péter Hauser more than expected).

Fields of papers citing papers by Péter Hauser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Péter Hauser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Péter Hauser. The network helps show where Péter Hauser may publish in the future.

Co-authorship network of co-authors of Péter Hauser

This figure shows the co-authorship network connecting the top 25 collaborators of Péter Hauser. A scholar is included among the top collaborators of Péter Hauser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Péter Hauser. Péter Hauser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hamon, Morgan, Yuzhen Chen, Vijay Gupta, et al.. (2023). Matrix Stiffness Influences Tubular Formation in Renal Tissue Engineering. Applied Sciences. 13(7). 4510–4510. 4 indexed citations
2.
Hauser, Péter, et al.. (2023). In Vivo Vascularization Chamber for the Implantation of Embryonic Kidneys. Tissue Engineering Part C Methods. 30(2). 63–72. 1 indexed citations
3.
Hamon, Morgan, et al.. (2022). Effect of Hypoxia on Branching Characteristics and Cell Subpopulations during Kidney Organ Culture. Bioengineering. 9(12). 801–801. 1 indexed citations
4.
Hauser, Péter, et al.. (2021). Bioprinting Scaffolds for Vascular Tissues and Tissue Vascularization. Bioengineering. 8(11). 178–178. 29 indexed citations
5.
Hauser, Péter, et al.. (2021). Nanotechnology, Nanomedicine, and the Kidney. Applied Sciences. 11(16). 7187–7187. 35 indexed citations
6.
Fleischmann, Jacob, et al.. (2020). Exonuclease resistant 18S and 25S ribosomal RNA components in yeast are possibly newly transcribed by RNA polymerase II. BMC Molecular and Cell Biology. 21(1). 59–59. 3 indexed citations
7.
Nishikawa, Masaki, Hiroshi Kimura, Morgan Hamon, et al.. (2018). Comprehensive analysis of chromatin signature and transcriptome uncovers functional lncRNAs expressed in nephron progenitor cells. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1862(1). 58–70. 7 indexed citations
8.
Fuller, Bret E., et al.. (2016). Co-occurring Depression, Chronic Pain and Substance Use Disorders in People with Hepatitis C. 3(1). 79–103. 2 indexed citations
9.
Fuller, Bret E., et al.. (2011). HIV Co-Testing Among Veterans with Chronic Hepatitis C in theVeterans Health Administration. 5(1). 91–96. 1 indexed citations
10.
Lotrich, Francis E., Jennifer M. Loftis, Robert E. Ferrell, Mordechai Rabinovitz, & Péter Hauser. (2010). IL28B Polymorphism Is Associated with Both Side Effects and Clearance of Hepatitis C During Interferon-Alpha Therapy. Journal of Interferon & Cytokine Research. 31(3). 331–336. 31 indexed citations
11.
Morasco, Benjamin J., Jennifer M. Loftis, David W. Indest, et al.. (2010). Prophylactic Antidepressant Treatment in Patients With Hepatitis C on Antiviral Therapy: A Double-Blind, Placebo-Controlled Trial. Psychosomatics. 51(5). 401–408. 30 indexed citations
12.
13.
Huckans, Marilyn, Adriana Seelye, Jonathan Woodhouse, et al.. (2009). The cognitive effects of hepatitis C in the presence and absence of a history of substance use disorder. Journal of the International Neuropsychological Society. 15(1). 69–82. 43 indexed citations
14.
Kilbourne, Amy M., John F. McCarthy, Seth Himelhoch, et al.. (2008). Guideline-concordant hepatitis C virus testing and notification among patients with and without mental disorders. General Hospital Psychiatry. 30(6). 495–500. 6 indexed citations
15.
Matthews, Annette M., Marilyn Huckans, Aaron D. Blackwell, & Péter Hauser. (2008). Hepatitis C testing and infection rates in bipolar patients with and without comorbid substance use disorders. Bipolar Disorders. 10(2). 266–270. 26 indexed citations
16.
Dobscha, Steven K., et al.. (2008). Pain, Substance Use Disorders and Opioid Analgesic Prescription Patterns in Veterans with Hepatitis C. Journal of Pain and Symptom Management. 36(1). 39–45. 41 indexed citations
17.
Matthews, Annette M. & Péter Hauser. (2008). Hepatitis C Screening in Bipolar Veterans. Addictive Disorders & Their Treatment. 7(1). 41–45. 1 indexed citations
18.
Huckans, Marilyn, et al.. (2008). Antiviral Therapy Completion and Response Rates Among Hepatitis C Patients With and Without Schizophrenia. Schizophrenia Bulletin. 36(1). 165–172. 24 indexed citations
19.
Morasco, Benjamin J., et al.. (2007). A randomized trial of paroxetine to prevent interferon-α-induced depression in patients with hepatitis C. Journal of Affective Disorders. 103(1-3). 83–90. 84 indexed citations
20.
Phillips, Susan A., Pnina Rotman‐Pikielny, Josef Lazar, et al.. (2001). Extreme Thyroid Hormone Resistance in a Patient with a Novel Truncated TR Mutant. The Journal of Clinical Endocrinology & Metabolism. 86(11). 5142–5147. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026